Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 57Neoplasms 40Prostatic Neoplasms 36Colorectal Neoplasms 36Carcinoma, Non-Small-Cell Lung 31Lung Neoplasms 30Pancreatic Neoplasms 21Leukemia, Myeloid, Acute 21Multiple Myeloma 17Carcinoma, Hepatocellular 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Stomach Neoplasms 12Recurrence 12Neoplasm Metastasis 11Squamous Cell Carcinoma of Head and Neck 10Ovarian Neoplasms 10Head and Neck Neoplasms 10Glioblastoma 10Uterine Cervical Neoplasms 9Melanoma 9Carcinoma, Renal Cell 9Lymphoma, B-Cell 8Endometrial Neoplasms 8Disease 8Brain Neoplasms 8Triple Negative Breast Neoplasms 7Rectal Neoplasms 7Lymphoma, Large B-Cell, Diffuse 7Esophageal Neoplasms 7Colonic Neoplasms 7

Interventions

Tadalafil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Erectile Dysfunction × 30 days × Clear all
NCT07576335 2026-05-08

ROBOPREP

Surgical Outcomes Research Centre (SOuRCe)

Phase 2 Not yet recruiting
64 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms, Urinary Incontinence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡